Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

MLA

H. Cody Meissner, et al. “Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.” Pediatrics, vol. 134, Aug. 2014, pp. 415–20. EBSCOhost, https://doi.org/10.1542/peds.2014-1665.

APA

H. Cody Meissner, Geoffrey L. Rosenthal, Jeffrey R. Starke, Richard L. Gorman, Joseph J. Zorc, Carrie L. Byington, Jennifer Frantz, Caryn Davidson, Marco Aurélio Palazzi Sáfadi, Jennifer S. Read, Michael J. Light, Mark H. Sawyer, Sinsi Hernandez-Cancio, Marc A. Fischer, Mark A. Brown, David W. Johnson, Henry H. Bernstein, Mobeen H. Rathore, Eneida A. Mendonça, … Walter A. Orenstein. (2014). Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics, 134, 415–420. https://doi.org/10.1542/peds.2014-1665

Chicago

H. Cody Meissner, Geoffrey L. Rosenthal, Jeffrey R. Starke, Richard L. Gorman, Joseph J. Zorc, Carrie L. Byington, Jennifer Frantz, et al. 2014. “Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.” Pediatrics 134 (August): 415–20. doi:10.1542/peds.2014-1665.